retatrutide fda approval status november 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Dosing Guide: 1-12 mg

Mochi Health Mochi charges a lower membership and flat compounded medication prices

Cagrilintide + retatrutide adds the amylin analog cagrilintide to reinforce satiety - useful when hunger is the main barrier

If a patch becomes dislodged, patients should follow the specific guidance provided with their medication or contact their healthcare provider for advice

Tirzepatide targets two gut hormones rather than one, and the clinical trial data reflects that difference

Actual cost depends on insurance coverage, pharmacy dispensing fees, and the dose youre prescribed

There is no wrong choice between these medications for most candidates